1. Tseng CH, Chen TT, Wu MY, Chan MC, Shih MC, Tu YK. Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network metaanalyses. Crit Care. 2020;24:693.

2. Joosten A, Coeckelenbergh S, Alexander B, et al. Hydroxyethyl starch for perioperative goal-directed fluid therapy in 2020: a narrative review. BMC Anesthesiol. 2020;20:209.

3. Haynes GR, Havidich JE, Payne KJ. Why the Food and Drug Administration changed the warning label for hetastarch. Anesthesiology. 2004;101:560-1.

4. https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyethyl-starch-hescontaining-medicinal-products

5. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/labelingchanges-mortality-kidney-injury-and-excess-bleeding-hydroxyethyl-starch-products

6. http://antigo.anvisa.gov.br/listagem-de-alertas/- /asset_publisher/R6VaZWsQDDzS/content/solucoes-de-hidroxietilamido-istarhes-plasminvolulyte-e-voluven-novas-informacoes-de-seguranca-das-solucoes-contendohidroxietilamido

7. Hartog CS, Reuter D, Loesche W, Hofmann M, Reinhart K. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med. 2011;37:1725-37.

8. Lewis SR, Pritchard MW, Evans DJ, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev. 2018;8:CD000567.

9. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-39.

10. Perner A, Haase N, Guttormsen AB, et al.; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124-34. Erratum in: N Engl J Med. 2012;367(5):481.

11. Myburgh JA, Finfer S, Bellomo R, et al.; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901-11. Erratum in: N Engl J Med. 2016;374(13):1298.

12. Lewis SR, Pritchard MW, Evans DJ, et al. Colloids versus crystalloids for fluid resuscitation in critically ill people. Cochrane Database Syst Rev. 2018;8:CD000567.

13. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2010;(1):CD007594.

14. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg. 2012;144:223-30.

15. Pensier J, Deffontis L, Rollé A, et al. Hydroxyethyl Starch for Fluid Management in Patients Undergoing Major Abdominal Surgery: A Systematic Review With Meta-analysis and Trial Sequential Analysis. Anesth Analg. 2022;134:686-95. Erratum in: Anesth Analg. 2022;135:e20. 

16. Wiedermann CJ. Human albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis revisited. BMC Surg. 2022;22:140.

17. Buhre W, de Korte-de Boer D, de Abreu MG, et al. Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study. Trials. 2022;23:168.

18. Palma CD, Mamba M, Geldenhuys J, et al. PragmaTic, prospEctive, randomized, controlled, double-blind, mulTi-centre, multinational study on the safety and efficacy of a 6% HydroxYethyl Starch (HES) solution versus an electrolyte solution in trauma patients: study protocol for the TETHYS study. Trials. 2022;23:456.